The Long-acting Beta Agonists Market size was valued at USD 5.1 Billion in 2022 and is projected to reach USD 7.8 Billion by 2030, growing at a CAGR of 6.5% from 2024 to 2030.
The Long-acting Beta Agonists (LABAs) market is primarily segmented based onÂ